Alternatively spliced variants of the cell adhesion molecule CD44 and tumour progression in colorectal cancer.
about
Alternative splicing for diseases, cancers, drugs, and databasesMolecular detection of low-level disease in patients with cancer.Detection and clinical significance of occult tumour cells in colorectal cancer.Germline polymorphisms in genes involved in the CD44 signaling pathway are associated with clinical outcome in localized gastric adenocarcinoma.Poor diagnostic value of colonic CD44v6 expression and serum concentrations of its soluble form in the differentiation of ulcerative colitis from Crohn's diseaseDetection of malignant cells in pleural fluid or ascites by CD44v8-10/CD44v10 competitive RT-PCR.Colon cancer: prevalence, screening, gene expression and mutation, and risk factors and assessment.Expression of proliferating cell nuclear antigen and CD44 variant exon 6 in primary tumors and corresponding lymph node metastases of colorectal carcinoma with Dukes' stage C or D.Development and progression of colorectal neoplasia.CD44v6 down-regulation is an independent prognostic factor for poor outcome of colorectal carcinoma.Biology of colorectal liver metastases: A review.Soluble CD44: quantification and molecular repartition in plasma of patients with colorectal cancerLimitations of CD44v6 amplification for the detection of tumour cells in the blood of colorectal cancer patients.Rac1 signaling modulates BCL-6-mediated repression of gene transcription.Butyrate down-regulates CD44 transcription and liver colonisation in a highly metastatic human colon carcinoma cell line.Characteristics of CD44 alternative splice pattern in the course of human colorectal adenocarcinoma progression.New-generation taxoid SB-T-1214 inhibits stem cell-related gene expression in 3D cancer spheroids induced by purified colon tumor-initiating cells.Interleukin-18 increases metastasis and immune escape of stomach cancer via the downregulation of CD70 and maintenance of CD44.The beta-catenin/TCF4 pathway modifies alternative splicing through modulation of SRp20 expression.Overexpression of CD44: a useful independent predictor of prognosis in patients with colorectal carcinomas.Decreased expression of CD44, alpha-catenin, and deleted colon carcinoma and altered expression of beta-catenin in ulcerative colitis-associated dysplasia and carcinoma, as compared with sporadic colon neoplasms.Expression of standard CD44 in human colorectal carcinoma: association with prognosis.Expression of CD44 variants in gastric carcinoma with or without Epstein-Barr virus.Down-regulation of CD44 standard and variant isoforms during the development and progression of uterine cervical tumours.Expression of CD44s in human colorectal cancer.Detection of colorectal cancer cells in peripheral blood by reverse-transcriptase polymerase chain reaction for cytokeratin 20.CD44 expression in normal, hyperplastic, and malignant endometrium.Comparison of cyclooxygenase-2 and CD44 mRNA expression in colorectal cancer and its relevance for prognosis.Up-regulation of CD44 variant exon expression in endometrial carcinomas: analysis of mRNA and protein isoforms, and relation to clinicopathological factors.Association of Two CD44 Polymorphisms with Clinical Outcomes of Gastric Cancer Patients
P2860
Q26852848-A9834F9D-3D1E-44D2-BA1B-A1265EBFBD2AQ33820786-0DE4DB3B-6C75-454C-892C-5C5DFA9B8B96Q34385776-56CAC2F9-0C33-48C6-9D95-AA54FF6BFCE3Q35114557-08DC1D28-9BA0-4AB0-A5AB-1B11DB1D2C55Q35352280-107ED1BC-A5A3-4E61-A8E9-45123DA54239Q35937491-37869B85-3B7F-4D9D-827D-F67219B138E9Q36104060-069EB570-8BC6-4B20-9D03-FA4CFE32F763Q36190651-52FE45B9-1082-4261-8F65-8E008CEF910BQ36241935-611FFB72-11C2-4DEB-9FB8-920AE562936DQ36464403-8A0A6B7C-F2FC-4F3F-ADBF-912565749C82Q36513872-CF48DF75-59D0-46A8-9251-609A21F72420Q36620617-9D575427-DEA6-4F9C-A074-1BAC3FAE52FBQ36641633-8CAFD57C-5858-4E07-A265-5A04F0A28653Q37275178-CB6CE098-EE51-4470-B2CB-919F94EA1503Q38360807-B5A199B5-027A-492C-8A05-574AACEA9461Q39244996-861F9DB4-F493-4A7D-B370-128028135F2BQ39680355-E961B6BB-D410-42E0-BC20-166C576F87C8Q39819769-F50214DA-E7AB-4AFF-88AE-1F9BAD07E9E5Q39924925-C2B887B4-FD98-41A8-BA03-CE9C97AA2D3DQ40841652-3469BD97-4EA1-4106-9D72-F8F4176C8D0FQ41756853-B842179A-FBA0-4484-AE2B-B2DCFF543FA3Q43649381-97B40859-76E8-4623-B248-0AF71EC58BE9Q44182041-649ABAAA-FEBC-4422-A986-3ADC250198C4Q44183424-49368C7B-85B6-44D5-9513-2D700F204C39Q44271201-AFCFA189-4844-4E3B-B960-C43C76EFDF78Q47916071-95742293-77BE-4827-9D7D-A440B12F6C7AQ48008880-F330C154-FE39-4378-80CE-E53C40F58E3AQ51773839-1BD61CBD-E7CC-4F95-9206-37E0C1E20578Q55305894-6E6794B8-5B12-49E3-8E16-B5C100FE0E97Q55561308-DE42B12A-7F73-4D1E-9BE1-352547BD473B
P2860
Alternatively spliced variants of the cell adhesion molecule CD44 and tumour progression in colorectal cancer.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Alternatively spliced variants ...... gression in colorectal cancer.
@ast
Alternatively spliced variants ...... gression in colorectal cancer.
@en
type
label
Alternatively spliced variants ...... gression in colorectal cancer.
@ast
Alternatively spliced variants ...... gression in colorectal cancer.
@en
prefLabel
Alternatively spliced variants ...... gression in colorectal cancer.
@ast
Alternatively spliced variants ...... gression in colorectal cancer.
@en
P2093
P2860
P356
P1476
Alternatively spliced variants ...... gression in colorectal cancer.
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.1996.364
P407
P577
1996-08-01T00:00:00Z
P5875
P6179
1029107286